Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
STEM trial results in the New England Journal of Medicine (NEJM) - Balt ...
The New England Journal of Medicine and NEJM Group partner with Wolters ...
New England Journal of Medicine - Ovid Tools & Resources Center ...
Sepsis and Septic Shock | New England Journal of Medicine
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell ...
Bundibugyo Virus Disease in 2026 — Clinical and Public Health Responses ...
Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma | New ...
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative ...
Metabolic Dysfunction–Associated Steatotic Liver Disease | New England ...
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis | New ...
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer ...
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated ...
Hemophagocytic Lymphohistiocytosis | New England Journal of Medicine
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection ...
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream ...
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic ...
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast ...
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma ...
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 ...
Vutrisiran in Patients with Transthyretin Amyloidosis with ...
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide | New ...
Long QT Syndrome | New England Journal of Medicine
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic ...
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction ...
Noninvasive Assessment of Liver Fibrosis | New England Journal of Medicine
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast ...
First-Line Zongertinib in Advanced HER2-Mutant Non–Small-Cell Lung ...
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia ...
VITT-like Monoclonal Gammopathy of Thrombotic Significance | New ...
Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major ...
Pulsed Field Ablation as Initial Therapy for Persistent Atrial ...
Talquetamab–Daratumumab in Relapsed or Refractory Myeloma | New England ...
Asundexian for Secondary Stroke Prevention | New England Journal of ...
Angiography-Derived Fractional Flow Reserve to Guide PCI | New England ...
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic ...
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced ...
Cervical Cancer | New England Journal of Medicine
New England Journal of Medicine (NEJM) Impact Factor - Journal Impact ...
Andes Hantavirus Outbreak on a Cruise Ship, 2026 | New England Journal ...
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity ...
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated ...
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for ...
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple ...
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity ...
Teclistamab in Multiple Myeloma with One to Three Previous Lines of ...
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis ...
Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung ...
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025 ...
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity ...
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic ...
Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis ...
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer ...
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant ...
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B ...
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early ...
Finerenone in Persons with Chronic Kidney Disease without Diabetes ...
Tirzepatide for Heart Failure with Preserved Ejection Fraction and ...
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy ...
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type ...
Daraxonrasib or Chemotherapy in Previously Treated Metastatic ...
Knihovna - NEJM (The New England Journal of Medicine) je prestižní ...
Het New England Journal of Medicine en NEJM Group werken samen met ...
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ...
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast ...
Survodutide Once Weekly for the Treatment of Adults with Obesity | New ...
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis | New ...
Inflammatory Myopathies | New England Journal of Medicine
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations ...
Das New England Journal of Medicine und die NEJM Group gehen mit ...
Internal Medicine Board Review — AMBOSS NEJM Knowledge+
Volume 1, No. 3 is now available! Here are the latest articles ...
NEJM - Medical Account Pro
Lorundrostat Efficacy and Safety in Patients with Uncontrolled ...
Protein-Losing Enteropathy | NEJM
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian ...
Vol. 3 No. 3 | NEJM AI
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS | NEJM
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic ...
Middle East Journal of Management (MEJM) Inderscience Publishers ...
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis | NEJM
NEJM AI: una nueva revista para explorar el potencial de la IA en la ...
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 ...
Another milestone in my professional development: I have successfully ...
Virtual Nursing to Improve Patient and Team Member Experiences at ...
Nejm Image Submission – Nejm Author Center – FBUGM
Transplantation Outcomes with Donor Hearts after Circulatory Death | NEJM
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C ...
New England Journal of Medicine (NEJM) - UM Library Online Databases ...
NEJM (New England Journal of Medicine) (1-year Subscription) $15.00 ...
Routine Functional Testing or Standard Care in High-Risk Patients after ...
Autosomal Dominant Osteopetrosis | NEJM
In-Hospital Mortality in Hemorrhagic Myocardial Infarction | NEJM Evidence
NEJM Interview: Andrew Hantel on a source of discrimination against ...
The Safety of Inpatient Health Care | NEJM
The Difficulty of Addressing Social Needs Through Health Care Alone ...
To Preserve or Not to Preserve the Infrapatellar Fat Pad in Knee ...
Volume 1, No. 5 is now available! Here are the latest articles ...
Smoking Cessation and Short- and Longer-Term Mortality | NEJM Evidence
Beyond the Counter: The Community Pharmacist of the Future | NEJM Catalyst
Evaluation of Human Factors–Related Risks in AI-Enabled Medical Devices ...
Nejm logo hi-res stock photography and images - Alamy
Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010 ...
A 109-Year-Old Pastime Beats a High-Tech Teenager | NEJM Evidence
Vol. 5 No. 2 | NEJM Evidence
NEJM Group on LinkedIn: New exclusive collection from NEJM. Get these ...
Awareness of Structural Racism Rises but Disparities in Care Delivery ...
The Promise of Animal Testing Alternatives at the U.S. Food and Drug ...
NEJM Subclinical Hypothyroidism - Af.es | PDF | Hipotiroidismo ...
Electronic Patient-Reported Outcomes in Oncology: Lessons from Six ...
From Consulting to Caring: Care Redesign in Idiopathic Pulmonary ...
Current Issue | NEJM AI
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen ...
Changing the Script on Drug Pricing: A New Type of Supplier Creates ...
Advancing Health Equity in a Time of Retrenchment: On Equity, Value ...
NEJM Print + Online
Influenza Virus Characteristics in Department of Defense Populations ...
'Now it's time for something new to start' - Remco Evenepoel ends seven ...
Lawrie Colaco posted on LinkedIn
